504 related articles for article (PubMed ID: 14756556)
1. Transition state structure for ADP-ribosylation of eukaryotic elongation factor 2 catalyzed by diphtheria toxin.
Parikh SL; Schramm VL
Biochemistry; 2004 Feb; 43(5):1204-12. PubMed ID: 14756556
[TBL] [Abstract][Full Text] [Related]
2. Kinetic isotope effect characterization of the transition state for oxidized nicotinamide adenine dinucleotide hydrolysis by pertussis toxin.
Scheuring J; Schramm VL
Biochemistry; 1997 Apr; 36(15):4526-34. PubMed ID: 9109661
[TBL] [Abstract][Full Text] [Related]
3. Pertussis toxin: transition state analysis for ADP-ribosylation of G-protein peptide alphai3C20.
Scheuring J; Schramm VL
Biochemistry; 1997 Jul; 36(27):8215-23. PubMed ID: 9204866
[TBL] [Abstract][Full Text] [Related]
4. Endogenous ADP-ribosylation for eukaryotic elongation factor 2: evidence of two different sites and reactions.
Bektaş M; Nurten R; Ergen K; Bermek E
Cell Biochem Funct; 2006; 24(4):369-80. PubMed ID: 16142694
[TBL] [Abstract][Full Text] [Related]
5. Inhibitors of ADP-ribosylating bacterial toxins based on oxacarbenium ion character at their transition states.
Zhou GC; Parikh SL; Tyler PC; Evans GB; Furneaux RH; Zubkova OV; Benjes PA; Schramm VL
J Am Chem Soc; 2004 May; 126(18):5690-8. PubMed ID: 15125661
[TBL] [Abstract][Full Text] [Related]
6. Endogenous ADP-ribosylation of eukaryotic elongation factor 2 and its 32 kDa tryptic fragment.
Ergen K; Bektaş M; Gökçe S; Nurten R
Biocell; 2007; 31(1):61-6. PubMed ID: 17665640
[TBL] [Abstract][Full Text] [Related]
7. Transition-state structure for the ADP-ribosylation of recombinant Gialpha1 subunits by pertussis toxin.
Scheuring J; Berti PJ; Schramm VL
Biochemistry; 1998 Mar; 37(9):2748-58. PubMed ID: 9485425
[TBL] [Abstract][Full Text] [Related]
8. Transition state structure of 5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase from Escherichia coli and its similarity to transition state analogues.
Singh V; Lee JE; Núñez S; Howell PL; Schramm VL
Biochemistry; 2005 Sep; 44(35):11647-59. PubMed ID: 16128565
[TBL] [Abstract][Full Text] [Related]
9. Effect of oxidative stress on in vivo ADP-ribosylation of eukaryotic elongation factor 2.
Bektaş M; Akçakaya H; Aroymak A; Nurten R; Bermek E
Int J Biochem Cell Biol; 2005 Jan; 37(1):91-9. PubMed ID: 15381153
[TBL] [Abstract][Full Text] [Related]
10. Active-site mutations of the diphtheria toxin catalytic domain: role of histidine-21 in nicotinamide adenine dinucleotide binding and ADP-ribosylation of elongation factor 2.
Blanke SR; Huang K; Wilson BA; Papini E; Covacci A; Collier RJ
Biochemistry; 1994 May; 33(17):5155-61. PubMed ID: 8172890
[TBL] [Abstract][Full Text] [Related]
11. Nucleophilic participation in the transition state for human thymidine phosphorylase.
Birck MR; Schramm VL
J Am Chem Soc; 2004 Mar; 126(8):2447-53. PubMed ID: 14982453
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure of diphtheria toxin bound to nicotinamide adenine dinucleotide.
Bell CE; Eisenberg D
Biochemistry; 1996 Jan; 35(4):1137-49. PubMed ID: 8573568
[TBL] [Abstract][Full Text] [Related]
13. Investigating the ADP-ribosyltransferase activity of sirtuins with NAD analogues and 32P-NAD.
Du J; Jiang H; Lin H
Biochemistry; 2009 Apr; 48(13):2878-90. PubMed ID: 19220062
[TBL] [Abstract][Full Text] [Related]
14. Cytoplasmic inhibitor of eEF-2 ADP-ribosylation catalyzed by diphtheria toxin or endogenous transferase in rat liver cells.
Galicka A; Sredzińska K; Gindzieński A
Biochem Biophys Res Commun; 2000 Mar; 269(2):553-6. PubMed ID: 10708592
[TBL] [Abstract][Full Text] [Related]
15. Diphtheria toxin. Site and configuration of ADP-ribosylation of diphthamide in elongation factor 2.
Oppenheimer NJ; Bodley JW
J Biol Chem; 1981 Aug; 256(16):8579-81. PubMed ID: 6267047
[TBL] [Abstract][Full Text] [Related]
16. 1-N6-Etheno-ADP-ribosylation of elongation factor-2 by diphtheria toxin.
Giovane A; Balestrieri C; Quagliuolo L; Servillo L
FEBS Lett; 1985 Oct; 191(2):191-4. PubMed ID: 2996930
[TBL] [Abstract][Full Text] [Related]
17. Toward the elucidation of the catalytic mechanism of the mono-ADP-ribosyltransferase activity of Pseudomonas aeruginosa exotoxin A.
Armstrong S; Merrill AR
Biochemistry; 2004 Jan; 43(1):183-94. PubMed ID: 14705944
[TBL] [Abstract][Full Text] [Related]
18. Introduction of additional charges as an aid in protein purification: isolation of elongation factor 2 from Sulfolobus acidocaldarius by preparative isoelectric focusing before and after ADP-ribosylation.
Siegmund KD; Klink F
Protein Expr Purif; 1994 Dec; 5(6):553-8. PubMed ID: 7858424
[TBL] [Abstract][Full Text] [Related]
19. Exotoxin A-eEF2 complex structure indicates ADP ribosylation by ribosome mimicry.
Jørgensen R; Merrill AR; Yates SP; Marquez VE; Schwan AL; Boesen T; Andersen GR
Nature; 2005 Aug; 436(7053):979-84. PubMed ID: 16107839
[TBL] [Abstract][Full Text] [Related]
20. Investigation into the catalytic role for the tryptophan residues within domain III of Pseudomonas aeruginosa exotoxin A.
Beattie BK; Prentice GA; Merrill AR
Biochemistry; 1996 Dec; 35(48):15134-42. PubMed ID: 8952460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
